Christa Thöne-Reineke
Christa Thöne-Reineke
Universitätsprofessorin Dr. vet. med.
Verified email at - Homepage
Cited by
Cited by
The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis
D Cota, G Marsicano, M Tschöp, Y Grübler, C Flachskamm, M Schubert, ...
The Journal of clinical investigation 112 (3), 423-431, 2003
Epigallocatechin gallate attenuates diet-induced obesity in mice by decreasing energy absorption and increasing fat oxidation
S Klaus, S Pültz, C Thöne-Reineke, S Wolfram
International journal of obesity 29 (6), 615-623, 2005
Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension.
B Hocher, C Thöne-Reineke, P Rohmeiss, F Schmager, T Slowinski, ...
The Journal of clinical investigation 99 (6), 1380-1389, 1997
PPARγ-activating angiotensin type-1 receptor blockers induce adiponectin
R Clasen, M Schupp, A Foryst-Ludwig, C Sprang, M Clemenz, M Krikov, ...
Hypertension 46 (1), 137-143, 2005
Does gut hormone PYY 3–36 decrease food intake in rodents?
M Tschöp, TR Castaneda, HG Joost, C Thöne-Reineke, S Ortmann, ...
Nature 430 (6996), 1-3, 2004
Direct angiotensin II type 2 receptor stimulation acts anti-inflammatory through epoxyeicosatrienoic acid and inhibition of nuclear factor κB
F Rompe, M Artuc, A Hallberg, M Alterman, K Ströder, ...
Hypertension 55 (4), 924-931, 2010
The paracrine endothelin system: pathophysiology and implications in clinical medicine.
B Hocher, C Thöne-Reineke, C Bauer, M Raschack, HH Neumayer
European journal of clinical chemistry and clinical biochemistry: journal of …, 1997
PYY3‐36 as an anti‐obesity drug target
MM Boggiano, PC Chandler, KD Oswald, RJ Rodgers, JE Blundell, Y Ishii, ...
obesity reviews 6 (4), 307-322, 2005
The β-lactam antibiotic, ceftriaxone, dramatically improves survival, increases glutamate uptake and induces neurotrophins in stroke
C Thöne-Reineke, C Neumann, P Namsolleck, K Schmerbach, M Krikov, ...
Journal of hypertension 26 (12), 2426-2435, 2008
Characterization of the renal phenotype of transgenic rats expressing the human endothelin-2 gene
B Hocher, L Liefeldt, C Thöne-Reineke, HD Orzechowski, A Distler, ...
Hypertension 28 (2), 196-201, 1996
Direct Angiotensin II Type 2 Receptor Stimulation in Nω-Nitro-l-Arginine-Methyl Ester–Induced Hypertension: The Effect on Pulse Wave Velocity and Aortic …
L Paulis, STR Becker, K Lucht, K Schwengel, S Slavic, E Kaschina, ...
Hypertension 59 (2), 485-492, 2012
Angiotensin receptor blockers and cerebral protection in stroke
C Thöne-Reineke, UM Steckelings, T Unger
Journal of Hypertension 24, S115-S121, 2006
Severity classification of repeated isoflurane anesthesia in C57BL/6JRj mice—Assessing the degree of distress
K Hohlbaum, B Bert, S Dietze, R Palme, H Fink, C Thöne-Reineke
PloS one 12 (6), e0179588, 2017
Renal endothelin system in polycystic kidney disease.
B Hocher, R Zart, A Schwarz, V Vogt, C Braun, C Thöne-Reineke, ...
Journal of the American Society of Nephrology 9 (7), 1169-1177, 1998
AT2-receptor stimulation enhances axonal plasticity after spinal cord injury by upregulating BDNF expression
P Namsolleck, F Boato, K Schwengel, L Paulis, KS Matho, N Geurts, ...
Neurobiology of disease 51, 177-191, 2013
Angiotensin type 2 receptor stimulation ameliorates left ventricular fibrosis and dysfunction via regulation of tissue inhibitor of matrix metalloproteinase 1/matrix …
D Lauer, S Slavic, M Sommerfeld, C Thöne-Reineke, Y Sharkovska, ...
Hypertension 63 (3), e60-e67, 2014
Cannabinoid receptor 1 inhibition improves cardiac function and remodelling after myocardial infarction and in experimental metabolic syndrome
S Slavic, D Lauer, M Sommerfeld, UR Kemnitz, A Grzesiak, M Trappiel, ...
Journal of Molecular Medicine 91 (7), 811-823, 2013
No effects of human ghrelin on cardiac function despite profound effects on body composition in a rat model of heart failure
YJ Akashi, S Palus, R Datta, H Halem, JE Taylor, C Thoene-Reineke, ...
International Journal of Cardiology 137 (3), 267-275, 2009
Are angiotensin receptor blockers neuroprotective?
C Thöne-Reineke, M Zimmermann, C Neumann, M Krikov, J Li, N Gerova, ...
Current hypertension reports 6 (4), 257-266, 2004
Comparison between single and combined treatment with candesartan and pioglitazone following transient focal ischemia in rat brain
K Schmerbach, JH Schefe, M Krikov, S Müller, A Villringer, U Kintscher, ...
Brain research 1208, 225-233, 2008
The system can't perform the operation now. Try again later.
Articles 1–20